Herbs & Botanicals

New research is demonstrating which blood sugar support ingredients are effective and the different ways in which they work.

The COVID-19 pandemic solidified elderberry's place in the immune-health market in 2020. Continued demand in 2021 will push innovation and new product development, but it's also critical to ensure quality and authenticity.

The COVID-19 pandemic plus an unclear legal future slowed CBD sales in 2020. Will CBD's prospects improve in 2021?

Gencor has launched a new proprietary and patented botanical ingredient called Calmaluma designed to support stress. The ingredient is an extract of Caralluma Fimbriata, an edible cactus from India.

The bipartisan bill has been introduced by Representatives Kurt Schrader (D-Oregon) and Morgan Griffith (R-Virginia) will make hemp-derived cannabidiol (CBD) lawful as a dietary supplement.

Predictions from Nutritional Outlook's esteemed Editorial Advisory Board.

A recently published study investigated the efficacy and safety of tetrahydrocurcuminoids (THCs) for oral care applications.

In the midst of a pandemic, consumers are putting greater value on the role of nutrients in good health.

Following an extended comment period, USDA made a number of revisions to rules regarding the testing, disposal, and regulation of hemp.

The New York State Department of Health recently proposed new cannabinoid hemp regulation which establishes requirements for licensure for extraction and manufacturing, as well as the sale of hemp-derived cannabidiol (CBD) products.

Medicinal mushrooms saw skyrocketing growth in 2020 during the COVID-19 pandemic. Is this the first step in their mainstream journey?

Dietary supplement industry associations and leaders share 2021 regulatory predictions.

TriNutra launched B’utyQuin black seed oil for cosmetic formulations, offering anti-inflammatory and antioxidant benefits through TriNutra’s breed of Nigella sativa, standardized to 3% thymoquinone.

Experts predict 2021’s hottest food and beverage flavors.

A recently-published study found that a branded eye health formula from Sabinsa Corp. called Macumax supported symptoms of age-related macular degeneration.

Muhammed Majeed, PhD, founder and chairman, Sami-Sabinsa Group published "Boswellin®- Anti-Inflammatory Adaptogen from Nature," the fourth book in a series on derivatives of Boswellia serrata,

FTC is taking action against six companies for allegedly making a wide range of scientifically unsubstantiated claims regarding CBD’s ability to treat serious health conditions such as cancer, heart disease, hypertension, and Alzheimer’s.

KGK Science has been contracted by Psyched Wellness, a Canadian health supplement company, to provide a regulatory package of services to support the launch of its Amanita muscaria mushroom extract in the U.S. and Canada.

The Council for Responsible Nutrition recently submitting comments regarding the Proposed Kentucky Administrative Regulation 902 KAR 45:190, hemp-derived cannabidiol products and labeling requirements.

Companion Sciences has announced the completion of a new trial testing tolerability and palatability of CBD and glucosamine chew in dogs with osteoarthritis.

A recently published study found that a Persicaria minor extract from HP Ingredients, called IQ200, supports cognitive health in subjects with mild cognitive impairment.

A recent study found that a patented hair serum from Sabinsa Corp. significantly improved hair health in healthy male and female subjects.

The company’s landmark cranberry health claim win will benefit consumers and the industry at large.

The boutique, family-owned laboratory has taken on industry Goliaths, powered by “tenacity, foresight, and a little crazy.”

CV Sciences is paving the way to hemp-derived-CBD’s mainstream success.